Gallium-68 labeled Ubiquicidin derived octapeptide as a potential infection imaging agent
Jyotsna Bhatt(Bhabha Atomic Research Centre), Ashutosh Dash(Bhabha Atomic Research Centre), Kamaleshwaran Koramadai Karuppusamy(Kovai Medical Center and Hospital), Haladhar Dev Sarma(Bhabha Atomic Research Centre), Krishnamohan Repaka, Mukesh Kumar(All India Institute of Medical Sciences Raipur), Ajit Shinto(Kovai Medical Center and Hospital), Aruna Korde(Bhabha Atomic Research Centre), Archana Mukherjee(Bhabha Atomic Research Centre)
Cited by 27
Related Papers
Production of 177Lu for Targeted Radionuclide Therapy: Available Options
|Nuclear Medicine and Molecular Imaging|2015|375
Sustained Availability of <sup>99m</sup>Tc: Possible Paths Forward
|Journal of Nuclear Medicine|2012|140
Peptide Receptor Radionuclide Therapy: An Overview
|Cancer Biotherapy and Radiopharmaceuticals|2015|122
Targeted Radionuclide Therapy - An Overview
|Current Radiopharmaceuticals|2013|117
Development of an electrochemical 90Sr–90Y generator for separation of 90Y suitable for targeted therapy
|Nuclear Medicine and Biology|2008|99